Sublingual Dosing Data

There is now specific sublingual dosing data available — here is the precise picture.

The Honest Bioavailability Context First

Before giving you a number, the relative absorption efficiency of each route matters significantly for calculating the right dose:​

Route	Relative Bioavailability	Notes
Injectable (subcutaneous)	100% — gold standard	Highest tissue concentration, 10–20x more effective than topical at equivalent doses
Sublingual (troche/strip)	Moderate-High	Bypasses first-pass liver metabolism — significantly better than swallowed oral
Topical serum	Low-Moderate	Skin barrier limits penetration considerably
Swallowed oral	Lowest	Digestive enzymes break down most of the peptide before absorption

Sublingual sits meaningfully above topical in effectiveness — though below injectable.​

---

The Specific Sublingual Dosage

Based on the most current 2026 dosing guidelines:

Element	Recommendation
Dose per strip/troche	50–200 mcg (micrograms — not milligrams)
Frequency	1–2 times daily
Total daily sublingual dose	100–400 mcg/day
Hold time under tongue	15–20 minutes minimum — the longer the better for mucosal absorption
Start dose	50–100 mcg once daily for the first 2 weeks
Maintenance dose	100–200 mcg twice daily once established
Cycle	30 days on, 14 days off — prevents receptor desensitisation ​

---

How This Compares to Injectable Dosing

For context:

• Injectable standard dose: 200 mcg–2 mg daily (subcutaneous)
• Pharmaceutical range for systemic effects: 0.5–2.5 mg per injection
• Sublingual effective range: 100–400 mcg daily

The sublingual dose is lower than injectable because bypassing first-pass liver metabolism means more of the peptide reaches systemic circulation intact compared to swallowed oral forms — though injectable still delivers 10–20x higher tissue concentrations at equivalent doses.​

---

The Strip Formulation Spec — Practically

For a sublingual strip to deliver 100–200 mcg effectively, the formulation would need:

• GHK-Cu content: 100–200 mcg per strip
• Strip dissolution time: 15–20 minutes — slow enough to maximise mucosal contact time
• pH: 5.5–6.5 — slightly acidic, matching the sublingual environment and maintaining peptide-copper bond stability
• Penetration enhancer — cyclodextrin or the betaine-tartaric acid ionic liquid system identified in the RSC study — to meaningfully improve mucosal penetration beyond a plain formulation​
• Copper chelation stability — the copper must remain complexed with the GHK peptide throughout dissolution; free copper ions are pro-oxidant and irritating to mucosal tissue​

---

Expected Timeline for Results at This Dose

Timeframe	What to Expect
Weeks 1–2	No visible change — peptide saturating target tissues
Weeks 3–4	Subtle improvements in skin texture and hydration
Weeks 6–8	Measurable reduction in fine lines, improved skin firmness
Week 12	Full collagen remodelling effect visible — the benchmark timeframe from clinical trials ​

The 100–200 mcg twice-daily sublingual protocol sits within the evidence-supported range and — if delivered via a well-formulated strip with a penetration enhancer — represents the most practical non-injectable route to achieving meaningful systemic GHK-Cu levels for both skin anti-ageing and broader systemic regenerative effects